Human B cell differentiation: Dependence on interactions with monocytes and T lymphocytes via CD40, CD80 (B7.1), and the CD2-ligands CD48 and CD58 (LFA-3)

Cell Biology International

Volumn 22, Issue 1, 1998, Pages 21-29

  Hoffmann, Jörg C ^a   Krüger, Hartmut ^a   Zielen, Stefan ^b   Bayer, Bettina ^b   Zeidler, Henning ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c NONE

Author keywords

B cell differentiation; CD2; CD48; CD58; Intercellular adhesion

Indexed keywords

B7 ANTIGEN; CD18 ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD48 ANTIGEN; CD5 ANTIGEN; CD59 ANTIGEN; CD72 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; DEPLETION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; RAT; T LYMPHOCYTE;

ANIMALIA;

EID: 0031987241     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1997.0208     Document Type: Article

References (42)

1. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med. 178:1993;669-674.
2. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol. 150:1993;3671-3680.
3. Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR. CD40 ligand is a T cell growth factor. Eur J Immunol. 23:1993;2326-2331.
4. Arulanandam AR, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med. 177:1993;1439-1450.
5. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 366:1993;76-79.
6. Bajorath J, Chalupny NJ, Marken JS, Siadak AW, Skonier J, Gordon M, Hollenbaugh D, Noelle RJ, Ochs HD, Aruffo A. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Biochemistry. 34:1995;1833-1844.
7. Banchereau J, Rousset F. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol. 52:1992;125-262.
8. Bazil V, Stefanova I, Hilgert I, Kristofova H, Vanek S, Bukovsky A, Horejsi V. Monoclonal antibodies against human leucocyte antigens. III. Antibodies against CD45R, CD6, CD44 and two newly described broadly expressed glycoproteins MEM-53 and MEM-102. Folia Biol Praha. 35:1989;289-297.
9. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature. 367:1994;425-428.
10. Damle NK, Linsley PS, Ledbetter JA. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7. Eur J Immunol. 21:1991;1277-1282.
11. Davis SJ, Van der Merwe PA. The structure and ligand interactions of CD2: implications for T-cell functions. Immunol Today. 17:1996;177-187.
12. Deckert M, Kubar J, Zoccola D, Bernard Pomier G, Angelisova P, Horejsi V, Bernard A. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur J Immunol. 22:1992;2943-2947.
13. Dengler TJ, Hoffmann JC, Knolle P, Albert Wolf M, Roux M, Wallich R, Meuer SC. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3). Eur J Immunol. 22:1992;2809-2817.
14. Diaz Sanchez D, Chegini S, Zhang K, Saxon A. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. J Immunol. 153:1994;10-20.
15. Dolen WK, Williams PB, Koepke JW, Selner JC. Immunoassay of specific IgE: low level assays require measurement of allergen specific assay background. Ann Allergy. 69:1992;151-156.
16. Emilie D, Wallon C, Galanaud P, Fischer A, Olive D, Delfraissy JF. Role of the LFA3-CD2 interaction in human specific B cell differentiation. J Immunol. 141:1988;1912-1918.
17. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol. 154:1995;4996-5010.
18. Gray JD, Horwitz DA. Activated human NK cells can stimulate resting B cells to secrete immunoglobulin. J Immunol. 154:1995;5656-5664.
19. Gückel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med. 174:1991;957-967.
20. Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science. 256:1992;1805-1807.
21. Hirokawa M, Gray JD, Takahashi T, Horwitz DA. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation. J Immunol. 149:1992;1859-1866.
22. Hoffmann JC, Dengler TJ, Knolle PA, Albert Wolf M, Roux M, Wallich R, Meuer SC. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids. Eur J Immunol. 23:1993;3003-3010.
23. Johnson JP, Stade BG, Hupke U, Holzmann B, Riethmuller G. The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1. Immunobiology. 178:1988;275-284.
24. Julius MH, Chiller JM, Sidman CL. Major histocompatibility complex-restricted cellular interactions determining B cell activation. Eur J Immunol. 12:1982;627-633.
25. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol. 152:1994;5643-5652.
26. Kozbor D, Moretta A, Messner HA, Moretta L, Croce CM. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J Immunol. 138:1987;4128-4132.
27. Kuiper HM, Brouwer M, Linsley PS, Van Lier RA. Activated T cells can induce high levels of CTLA-4 expression on B cells. J Immunol. 155:1995;1776-1783.
28. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol. 152:1994;2163-2171.
29. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med. 174:1991;561-569.
30. Morgan BP, Van den Berg CW, Davies EV, Hallett MB, Horejsi V. Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase. Eur J Immunol. 23:1993;2841-2850.
31. Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol. 153:1994;1027-1036.
32. Shiba K, Stohl W, Gray JD, Horwitz DA. A novel role for accessory cells in T cell-dependent B cell differentiation. Cell Immunol. 127:1990;458-469.
33. Silvy A, Lagresle C, Bella C, Defrance T. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur J Immunol. 26:1996;517-524.
34. Stohl W, Crow MK. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Cell Immunol. 130:1990;257-270.
35. Thiele DL, Lipsky PE. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mono-nuclear cells. J Immunol. 134:1985;786-793.
36. Tohma S, Hirohata S, Lipsky PE. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation. J Immunol. 146:1991;492-499.
37. Valle A, Garrone P, Yssel H, Bonnefoy JY, Freedman AS, Freeman G, Nadler LM, Banchereau J. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology. 69:1990;531-535.
38. Van de Velde, H, 1995, Identification and functional aspects of CD5/CD72 interaction. Vrije Universiteit Brussel.
39. Van Lier RA, Brouwer M, Aarden LA. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur J Immunol. 18:1988;167-172.
40. Vernino L, McAnally LM, Ramberg J, Lipsky PE. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J Immunol. 148:1992;404-410.
41. Virella G, Rugeles MT, Hyman B, La Via M, Goust JM, Frankis M, Bierer BE. The interaction of CD2 with its LFA-3 ligand expressed by autologous erythrocytes results in enhancement of B cell responses. Cell Immunol. 116:1988;308-319.
42. Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman Nir E, Sippel KC, Rogers J, Cleary AM, Parker M, Chess L, Lederman S. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol. 153:1994;666-674.